Open AccessReview of once-monthly oral ibandronate and the use thereof
Author(s) -
T de Villiers,
Monica Davey,
Bilkish Cassim,
W. Lange
Publication year - 2017
Publication title -
south african family practice
Language(s) - English
Resource type - Journals
eISSN - 2078-6204
pISSN - 2078-6190
DOI - 10.4102/safp.v59i4.4728
Subject(s) - postmenopausal osteoporosis , medicine , osteoporosis , postmenopausal women , bone mineral
An advisory board meeting of key opinion leaders was held in 2015 to discuss the clinical data on oral ibandronate in the treatment of postmenopausal osteoporosis.
Boniva 150 mg (ibandronate) oral once-monthly is indicated for the treatment of osteoporosis in postmenopausal women, in order to reduce the risk of vertebral fractures.1